nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—prostate cancer	0.174	0.614	CbGaD
Fingolimod—CYP3A4—prostate cancer	0.109	0.386	CbGaD
Fingolimod—CYP2E1—Estrone—prostate cancer	0.0376	0.122	CbGbCtD
Fingolimod—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0362	0.117	CbGbCtD
Fingolimod—CYP2D6—Bicalutamide—prostate cancer	0.0299	0.097	CbGbCtD
Fingolimod—CYP2D6—Abiraterone—prostate cancer	0.0248	0.0803	CbGbCtD
Fingolimod—CYP2E1—Mitoxantrone—prostate cancer	0.0224	0.0725	CbGbCtD
Fingolimod—CYP3A4—Bicalutamide—prostate cancer	0.019	0.0617	CbGbCtD
Fingolimod—CYP3A4—Estramustine—prostate cancer	0.0177	0.0573	CbGbCtD
Fingolimod—CYP3A4—Abiraterone—prostate cancer	0.0158	0.0511	CbGbCtD
Fingolimod—CYP3A4—Flutamide—prostate cancer	0.0158	0.0511	CbGbCtD
Fingolimod—CYP2E1—Etoposide—prostate cancer	0.0141	0.0457	CbGbCtD
Fingolimod—CYP3A4—Cabazitaxel—prostate cancer	0.0117	0.0378	CbGbCtD
Fingolimod—CYP3A4—Estrone—prostate cancer	0.0114	0.0369	CbGbCtD
Fingolimod—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0102	0.0329	CbGbCtD
Fingolimod—CYP3A4—Conjugated Estrogens—prostate cancer	0.00746	0.0242	CbGbCtD
Fingolimod—CYP3A4—Mitoxantrone—prostate cancer	0.00678	0.022	CbGbCtD
Fingolimod—CYP3A4—Estradiol—prostate cancer	0.00655	0.0212	CbGbCtD
Fingolimod—S1PR5—prostate gland—prostate cancer	0.00577	0.0714	CbGeAlD
Fingolimod—CYP3A4—Prednisone—prostate cancer	0.00563	0.0182	CbGbCtD
Fingolimod—CYP4F2—prostate gland—prostate cancer	0.00541	0.0669	CbGeAlD
Fingolimod—S1PR3—prostate gland—prostate cancer	0.0048	0.0594	CbGeAlD
Fingolimod—CYP2D6—Doxorubicin—prostate cancer	0.00459	0.0149	CbGbCtD
Fingolimod—CYP3A4—Etoposide—prostate cancer	0.00428	0.0139	CbGbCtD
Fingolimod—S1PR1—prostate gland—prostate cancer	0.00423	0.0523	CbGeAlD
Fingolimod—SPHK1—prostate gland—prostate cancer	0.00418	0.0518	CbGeAlD
Fingolimod—CYP4F12—prostate gland—prostate cancer	0.00402	0.0498	CbGeAlD
Fingolimod—CYP3A4—Docetaxel—prostate cancer	0.00391	0.0127	CbGbCtD
Fingolimod—CYP4F2—renal system—prostate cancer	0.00369	0.0456	CbGeAlD
Fingolimod—S1PR4—bone marrow—prostate cancer	0.00354	0.0438	CbGeAlD
Fingolimod—CYP4F12—seminal vesicle—prostate cancer	0.0034	0.0421	CbGeAlD
Fingolimod—S1PR1—epithelium—prostate cancer	0.00311	0.0385	CbGeAlD
Fingolimod—CYP3A4—Doxorubicin—prostate cancer	0.00292	0.00945	CbGbCtD
Fingolimod—SPHK1—renal system—prostate cancer	0.00285	0.0353	CbGeAlD
Fingolimod—SPHK1—urethra—prostate cancer	0.0028	0.0347	CbGeAlD
Fingolimod—CYP4F2—bone marrow—prostate cancer	0.00279	0.0345	CbGeAlD
Fingolimod—CYP4F12—urethra—prostate cancer	0.00269	0.0333	CbGeAlD
Fingolimod—S1PR4—lymph node—prostate cancer	0.00219	0.0272	CbGeAlD
Fingolimod—S1PR3—testis—prostate cancer	0.00211	0.0262	CbGeAlD
Fingolimod—CYP4F12—bone marrow—prostate cancer	0.00207	0.0256	CbGeAlD
Fingolimod—CYP2E1—urine—prostate cancer	0.00189	0.0234	CbGeAlD
Fingolimod—S1PR1—testis—prostate cancer	0.00186	0.0231	CbGeAlD
Fingolimod—SPHK1—testis—prostate cancer	0.00184	0.0228	CbGeAlD
Fingolimod—S1PR5—lymph node—prostate cancer	0.00184	0.0228	CbGeAlD
Fingolimod—CYP4F12—testis—prostate cancer	0.00177	0.0219	CbGeAlD
Fingolimod—S1PR3—lymph node—prostate cancer	0.00153	0.019	CbGeAlD
Fingolimod—CYP3A4—urine—prostate cancer	0.00152	0.0188	CbGeAlD
Fingolimod—CYP2D6—urine—prostate cancer	0.00149	0.0185	CbGeAlD
Fingolimod—S1PR1—lymph node—prostate cancer	0.00135	0.0167	CbGeAlD
Fingolimod—SPHK1—lymph node—prostate cancer	0.00134	0.0165	CbGeAlD
Fingolimod—CYP4F12—lymph node—prostate cancer	0.00128	0.0159	CbGeAlD
Fingolimod—SPHK1—Betamethasone—Prednisone—prostate cancer	0.000874	0.5	CbGdCrCtD
Fingolimod—SPHK1—Dexamethasone—Prednisone—prostate cancer	0.000874	0.5	CbGdCrCtD
Fingolimod—CYP2E1—prostate gland—prostate cancer	0.000678	0.00839	CbGeAlD
Fingolimod—CYP2E1—seminal vesicle—prostate cancer	0.000573	0.0071	CbGeAlD
Fingolimod—CYP2E1—renal system—prostate cancer	0.000462	0.00572	CbGeAlD
Fingolimod—CYP2E1—urethra—prostate cancer	0.000454	0.00562	CbGeAlD
Fingolimod—CYP3A4—renal system—prostate cancer	0.000372	0.0046	CbGeAlD
Fingolimod—CYP2D6—renal system—prostate cancer	0.000366	0.00453	CbGeAlD
Fingolimod—CYP2E1—testis—prostate cancer	0.000299	0.0037	CbGeAlD
Fingolimod—CYP2D6—testis—prostate cancer	0.000236	0.00293	CbGeAlD
Fingolimod—Headache—Bicalutamide—prostate cancer	0.000149	0.00107	CcSEcCtD
Fingolimod—Paraesthesia—Goserelin—prostate cancer	0.000148	0.00106	CcSEcCtD
Fingolimod—Dyspnoea—Goserelin—prostate cancer	0.000147	0.00106	CcSEcCtD
Fingolimod—Paraesthesia—Conjugated Estrogens—prostate cancer	0.000147	0.00105	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Capecitabine—prostate cancer	0.000146	0.00105	CcSEcCtD
Fingolimod—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000146	0.00105	CcSEcCtD
Fingolimod—Back pain—Mitoxantrone—prostate cancer	0.000144	0.00104	CcSEcCtD
Fingolimod—Asthenia—Ethinyl Estradiol—prostate cancer	0.000144	0.00103	CcSEcCtD
Fingolimod—Influenza—Capecitabine—prostate cancer	0.000143	0.00103	CcSEcCtD
Fingolimod—Fatigue—Goserelin—prostate cancer	0.000142	0.00102	CcSEcCtD
Fingolimod—Pruritus—Ethinyl Estradiol—prostate cancer	0.000142	0.00102	CcSEcCtD
Fingolimod—Palpitations—Estradiol—prostate cancer	0.000142	0.00102	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Conjugated Estrogens—prostate cancer	0.000141	0.00101	CcSEcCtD
Fingolimod—Fatigue—Conjugated Estrogens—prostate cancer	0.000141	0.00101	CcSEcCtD
Fingolimod—Vision blurred—Mitoxantrone—prostate cancer	0.000141	0.00101	CcSEcCtD
Fingolimod—Cardiac arrest—Prednisone—prostate cancer	0.00014	0.00101	CcSEcCtD
Fingolimod—Cough—Estradiol—prostate cancer	0.00014	0.001	CcSEcCtD
Fingolimod—Hypertension—Estradiol—prostate cancer	0.000138	0.000993	CcSEcCtD
Fingolimod—Bronchitis—Capecitabine—prostate cancer	0.000138	0.00099	CcSEcCtD
Fingolimod—Diarrhoea—Ethinyl Estradiol—prostate cancer	0.000137	0.000984	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Estradiol—prostate cancer	0.000135	0.000972	CcSEcCtD
Fingolimod—Weight decreased—Docetaxel—prostate cancer	0.000134	0.000962	CcSEcCtD
Fingolimod—Leukopenia—Mitoxantrone—prostate cancer	0.000134	0.000959	CcSEcCtD
Fingolimod—Eye disorder—Etoposide—prostate cancer	0.000133	0.000957	CcSEcCtD
Fingolimod—Pneumonia—Docetaxel—prostate cancer	0.000133	0.000953	CcSEcCtD
Fingolimod—Dizziness—Ethinyl Estradiol—prostate cancer	0.000133	0.000951	CcSEcCtD
Fingolimod—Cardiac disorder—Etoposide—prostate cancer	0.000132	0.00095	CcSEcCtD
Fingolimod—Infestation NOS—Docetaxel—prostate cancer	0.000132	0.000948	CcSEcCtD
Fingolimod—Infestation—Docetaxel—prostate cancer	0.000132	0.000948	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Prednisone—prostate cancer	0.00013	0.000935	CcSEcCtD
Fingolimod—Cough—Mitoxantrone—prostate cancer	0.00013	0.000935	CcSEcCtD
Fingolimod—Infection—Estradiol—prostate cancer	0.00013	0.000932	CcSEcCtD
Fingolimod—Weight decreased—Capecitabine—prostate cancer	0.00013	0.000931	CcSEcCtD
Fingolimod—Angiopathy—Etoposide—prostate cancer	0.000129	0.000929	CcSEcCtD
Fingolimod—Hypertension—Mitoxantrone—prostate cancer	0.000129	0.000925	CcSEcCtD
Fingolimod—Eczema—Epirubicin—prostate cancer	0.000129	0.000923	CcSEcCtD
Fingolimod—Pneumonia—Capecitabine—prostate cancer	0.000129	0.000923	CcSEcCtD
Fingolimod—Mediastinal disorder—Etoposide—prostate cancer	0.000129	0.000923	CcSEcCtD
Fingolimod—Nervous system disorder—Estradiol—prostate cancer	0.000128	0.00092	CcSEcCtD
Fingolimod—Eye pain—Epirubicin—prostate cancer	0.000128	0.000919	CcSEcCtD
Fingolimod—Infestation NOS—Capecitabine—prostate cancer	0.000128	0.000918	CcSEcCtD
Fingolimod—Infestation—Capecitabine—prostate cancer	0.000128	0.000918	CcSEcCtD
Fingolimod—Depression—Capecitabine—prostate cancer	0.000127	0.000915	CcSEcCtD
Fingolimod—Skin disorder—Estradiol—prostate cancer	0.000127	0.000912	CcSEcCtD
Fingolimod—Alopecia—Etoposide—prostate cancer	0.000126	0.000905	CcSEcCtD
Fingolimod—Headache—Ethinyl Estradiol—prostate cancer	0.000126	0.000901	CcSEcCtD
Fingolimod—Infection—Mitoxantrone—prostate cancer	0.000121	0.000869	CcSEcCtD
Fingolimod—Back pain—Etoposide—prostate cancer	0.00012	0.000862	CcSEcCtD
Fingolimod—Eczema—Doxorubicin—prostate cancer	0.000119	0.000854	CcSEcCtD
Fingolimod—Eye pain—Doxorubicin—prostate cancer	0.000118	0.00085	CcSEcCtD
Fingolimod—Asthenia—Goserelin—prostate cancer	0.000118	0.000849	CcSEcCtD
Fingolimod—Skin disorder—Mitoxantrone—prostate cancer	0.000118	0.000849	CcSEcCtD
Fingolimod—Cerebrovascular accident—Epirubicin—prostate cancer	0.000118	0.000847	CcSEcCtD
Fingolimod—Paraesthesia—Estradiol—prostate cancer	0.000117	0.000843	CcSEcCtD
Fingolimod—Asthenia—Conjugated Estrogens—prostate cancer	0.000117	0.000841	CcSEcCtD
Fingolimod—Bradycardia—Capecitabine—prostate cancer	0.000117	0.000839	CcSEcCtD
Fingolimod—Pruritus—Goserelin—prostate cancer	0.000117	0.000838	CcSEcCtD
Fingolimod—Dyspnoea—Estradiol—prostate cancer	0.000117	0.000837	CcSEcCtD
Fingolimod—Connective tissue disorder—Docetaxel—prostate cancer	0.000116	0.000836	CcSEcCtD
Fingolimod—Pruritus—Conjugated Estrogens—prostate cancer	0.000116	0.00083	CcSEcCtD
Fingolimod—Weight decreased—Prednisone—prostate cancer	0.000116	0.000829	CcSEcCtD
Fingolimod—Hypotension—Mitoxantrone—prostate cancer	0.000114	0.000817	CcSEcCtD
Fingolimod—Migraine—Epirubicin—prostate cancer	0.000114	0.000817	CcSEcCtD
Fingolimod—Depression—Prednisone—prostate cancer	0.000114	0.000815	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Estradiol—prostate cancer	0.000113	0.00081	CcSEcCtD
Fingolimod—Diarrhoea—Goserelin—prostate cancer	0.000113	0.00081	CcSEcCtD
Fingolimod—Connective tissue disorder—Capecitabine—prostate cancer	0.000113	0.000809	CcSEcCtD
Fingolimod—Fatigue—Estradiol—prostate cancer	0.000113	0.000809	CcSEcCtD
Fingolimod—Diarrhoea—Conjugated Estrogens—prostate cancer	0.000112	0.000802	CcSEcCtD
Fingolimod—Leukopenia—Etoposide—prostate cancer	0.000111	0.000798	CcSEcCtD
Fingolimod—Eye disorder—Docetaxel—prostate cancer	0.000111	0.000795	CcSEcCtD
Fingolimod—Cardiac disorder—Docetaxel—prostate cancer	0.00011	0.00079	CcSEcCtD
Fingolimod—Cardiac arrest—Epirubicin—prostate cancer	0.00011	0.000789	CcSEcCtD
Fingolimod—Paraesthesia—Mitoxantrone—prostate cancer	0.000109	0.000785	CcSEcCtD
Fingolimod—Cerebrovascular accident—Doxorubicin—prostate cancer	0.000109	0.000783	CcSEcCtD
Fingolimod—Dizziness—Goserelin—prostate cancer	0.000109	0.000783	CcSEcCtD
Fingolimod—Dyspnoea—Mitoxantrone—prostate cancer	0.000109	0.00078	CcSEcCtD
Fingolimod—Cough—Etoposide—prostate cancer	0.000108	0.000778	CcSEcCtD
Fingolimod—Dizziness—Conjugated Estrogens—prostate cancer	0.000108	0.000775	CcSEcCtD
Fingolimod—Angiopathy—Docetaxel—prostate cancer	0.000108	0.000772	CcSEcCtD
Fingolimod—Eye disorder—Capecitabine—prostate cancer	0.000107	0.00077	CcSEcCtD
Fingolimod—Hypertension—Etoposide—prostate cancer	0.000107	0.000769	CcSEcCtD
Fingolimod—Mediastinal disorder—Docetaxel—prostate cancer	0.000107	0.000767	CcSEcCtD
Fingolimod—Liver function test abnormal—Epirubicin—prostate cancer	0.000107	0.000766	CcSEcCtD
Fingolimod—Cardiac disorder—Capecitabine—prostate cancer	0.000107	0.000765	CcSEcCtD
Fingolimod—Migraine—Doxorubicin—prostate cancer	0.000105	0.000756	CcSEcCtD
Fingolimod—Fatigue—Mitoxantrone—prostate cancer	0.000105	0.000754	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	0.000105	0.000754	CcSEcCtD
Fingolimod—Alopecia—Docetaxel—prostate cancer	0.000105	0.000752	CcSEcCtD
Fingolimod—Angiopathy—Capecitabine—prostate cancer	0.000104	0.000747	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Epirubicin—prostate cancer	0.000104	0.000747	CcSEcCtD
Fingolimod—Bradycardia—Prednisone—prostate cancer	0.000104	0.000747	CcSEcCtD
Fingolimod—Mental disorder—Docetaxel—prostate cancer	0.000104	0.000745	CcSEcCtD
Fingolimod—Mediastinal disorder—Capecitabine—prostate cancer	0.000103	0.000742	CcSEcCtD
Fingolimod—Headache—Goserelin—prostate cancer	0.000103	0.000742	CcSEcCtD
Fingolimod—Headache—Conjugated Estrogens—prostate cancer	0.000102	0.000735	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Epirubicin—prostate cancer	0.000102	0.000732	CcSEcCtD
Fingolimod—Cardiac arrest—Doxorubicin—prostate cancer	0.000102	0.00073	CcSEcCtD
Fingolimod—Alopecia—Capecitabine—prostate cancer	0.000101	0.000728	CcSEcCtD
Fingolimod—Infection—Etoposide—prostate cancer	0.000101	0.000723	CcSEcCtD
Fingolimod—Mental disorder—Capecitabine—prostate cancer	0.000101	0.000722	CcSEcCtD
Fingolimod—Connective tissue disorder—Prednisone—prostate cancer	0.0001	0.000721	CcSEcCtD
Fingolimod—Influenza—Epirubicin—prostate cancer	9.99e-05	0.000717	CcSEcCtD
Fingolimod—Back pain—Docetaxel—prostate cancer	9.98e-05	0.000716	CcSEcCtD
Fingolimod—Liver function test abnormal—Doxorubicin—prostate cancer	9.87e-05	0.000709	CcSEcCtD
Fingolimod—Skin disorder—Etoposide—prostate cancer	9.84e-05	0.000707	CcSEcCtD
Fingolimod—Back pain—Capecitabine—prostate cancer	9.66e-05	0.000694	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Doxorubicin—prostate cancer	9.63e-05	0.000691	CcSEcCtD
Fingolimod—Bronchitis—Epirubicin—prostate cancer	9.61e-05	0.00069	CcSEcCtD
Fingolimod—Eye disorder—Prednisone—prostate cancer	9.55e-05	0.000686	CcSEcCtD
Fingolimod—Hypotension—Etoposide—prostate cancer	9.47e-05	0.00068	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Doxorubicin—prostate cancer	9.43e-05	0.000677	CcSEcCtD
Fingolimod—Vision blurred—Capecitabine—prostate cancer	9.41e-05	0.000676	CcSEcCtD
Fingolimod—Asthenia—Estradiol—prostate cancer	9.38e-05	0.000673	CcSEcCtD
Fingolimod—Angiopathy—Prednisone—prostate cancer	9.27e-05	0.000666	CcSEcCtD
Fingolimod—Pruritus—Estradiol—prostate cancer	9.25e-05	0.000664	CcSEcCtD
Fingolimod—Influenza—Doxorubicin—prostate cancer	9.24e-05	0.000663	CcSEcCtD
Fingolimod—Leukopenia—Docetaxel—prostate cancer	9.24e-05	0.000663	CcSEcCtD
Fingolimod—Palpitations—Docetaxel—prostate cancer	9.12e-05	0.000655	CcSEcCtD
Fingolimod—Paraesthesia—Etoposide—prostate cancer	9.1e-05	0.000653	CcSEcCtD
Fingolimod—Weight decreased—Epirubicin—prostate cancer	9.04e-05	0.000649	CcSEcCtD
Fingolimod—Dyspnoea—Etoposide—prostate cancer	9.03e-05	0.000648	CcSEcCtD
Fingolimod—Alopecia—Prednisone—prostate cancer	9.03e-05	0.000648	CcSEcCtD
Fingolimod—Cough—Docetaxel—prostate cancer	9e-05	0.000646	CcSEcCtD
Fingolimod—Pneumonia—Epirubicin—prostate cancer	8.96e-05	0.000643	CcSEcCtD
Fingolimod—Mental disorder—Prednisone—prostate cancer	8.96e-05	0.000643	CcSEcCtD
Fingolimod—Diarrhoea—Estradiol—prostate cancer	8.95e-05	0.000642	CcSEcCtD
Fingolimod—Leukopenia—Capecitabine—prostate cancer	8.94e-05	0.000642	CcSEcCtD
Fingolimod—Hypertension—Docetaxel—prostate cancer	8.91e-05	0.000639	CcSEcCtD
Fingolimod—Infestation NOS—Epirubicin—prostate cancer	8.91e-05	0.000639	CcSEcCtD
Fingolimod—Infestation—Epirubicin—prostate cancer	8.91e-05	0.000639	CcSEcCtD
Fingolimod—Bronchitis—Doxorubicin—prostate cancer	8.89e-05	0.000638	CcSEcCtD
Fingolimod—Palpitations—Capecitabine—prostate cancer	8.83e-05	0.000634	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Etoposide—prostate cancer	8.75e-05	0.000628	CcSEcCtD
Fingolimod—Asthenia—Mitoxantrone—prostate cancer	8.74e-05	0.000627	CcSEcCtD
Fingolimod—Fatigue—Etoposide—prostate cancer	8.74e-05	0.000627	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	8.72e-05	0.000626	CcSEcCtD
Fingolimod—Cough—Capecitabine—prostate cancer	8.72e-05	0.000626	CcSEcCtD
Fingolimod—Dizziness—Estradiol—prostate cancer	8.65e-05	0.000621	CcSEcCtD
Fingolimod—Hypertension—Capecitabine—prostate cancer	8.62e-05	0.000619	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	8.45e-05	0.000606	CcSEcCtD
Fingolimod—Vision blurred—Prednisone—prostate cancer	8.39e-05	0.000602	CcSEcCtD
Fingolimod—Infection—Docetaxel—prostate cancer	8.37e-05	0.000601	CcSEcCtD
Fingolimod—Weight decreased—Doxorubicin—prostate cancer	8.36e-05	0.0006	CcSEcCtD
Fingolimod—Sinusitis—Epirubicin—prostate cancer	8.35e-05	0.0006	CcSEcCtD
Fingolimod—Diarrhoea—Mitoxantrone—prostate cancer	8.33e-05	0.000598	CcSEcCtD
Fingolimod—Pneumonia—Doxorubicin—prostate cancer	8.29e-05	0.000595	CcSEcCtD
Fingolimod—Nervous system disorder—Docetaxel—prostate cancer	8.26e-05	0.000593	CcSEcCtD
Fingolimod—Infestation—Doxorubicin—prostate cancer	8.24e-05	0.000592	CcSEcCtD
Fingolimod—Infestation NOS—Doxorubicin—prostate cancer	8.24e-05	0.000592	CcSEcCtD
Fingolimod—Headache—Estradiol—prostate cancer	8.19e-05	0.000588	CcSEcCtD
Fingolimod—Skin disorder—Docetaxel—prostate cancer	8.18e-05	0.000587	CcSEcCtD
Fingolimod—Bradycardia—Epirubicin—prostate cancer	8.14e-05	0.000584	CcSEcCtD
Fingolimod—Infection—Capecitabine—prostate cancer	8.1e-05	0.000581	CcSEcCtD
Fingolimod—Nervous system disorder—Capecitabine—prostate cancer	8e-05	0.000574	CcSEcCtD
Fingolimod—Skin disorder—Capecitabine—prostate cancer	7.92e-05	0.000568	CcSEcCtD
Fingolimod—Hypotension—Docetaxel—prostate cancer	7.87e-05	0.000565	CcSEcCtD
Fingolimod—Connective tissue disorder—Epirubicin—prostate cancer	7.86e-05	0.000564	CcSEcCtD
Fingolimod—Sinusitis—Doxorubicin—prostate cancer	7.73e-05	0.000555	CcSEcCtD
Fingolimod—Hypertension—Prednisone—prostate cancer	7.68e-05	0.000551	CcSEcCtD
Fingolimod—Headache—Mitoxantrone—prostate cancer	7.63e-05	0.000548	CcSEcCtD
Fingolimod—Hypotension—Capecitabine—prostate cancer	7.62e-05	0.000547	CcSEcCtD
Fingolimod—Paraesthesia—Docetaxel—prostate cancer	7.56e-05	0.000543	CcSEcCtD
Fingolimod—Bradycardia—Doxorubicin—prostate cancer	7.53e-05	0.000541	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	7.52e-05	0.00054	CcSEcCtD
Fingolimod—Dyspnoea—Docetaxel—prostate cancer	7.51e-05	0.000539	CcSEcCtD
Fingolimod—Eye disorder—Epirubicin—prostate cancer	7.47e-05	0.000536	CcSEcCtD
Fingolimod—Cardiac disorder—Epirubicin—prostate cancer	7.42e-05	0.000533	CcSEcCtD
Fingolimod—Paraesthesia—Capecitabine—prostate cancer	7.32e-05	0.000526	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Docetaxel—prostate cancer	7.27e-05	0.000522	CcSEcCtD
Fingolimod—Asthenia—Etoposide—prostate cancer	7.27e-05	0.000522	CcSEcCtD
Fingolimod—Connective tissue disorder—Doxorubicin—prostate cancer	7.27e-05	0.000522	CcSEcCtD
Fingolimod—Dyspnoea—Capecitabine—prostate cancer	7.27e-05	0.000522	CcSEcCtD
Fingolimod—Fatigue—Docetaxel—prostate cancer	7.26e-05	0.000521	CcSEcCtD
Fingolimod—Angiopathy—Epirubicin—prostate cancer	7.25e-05	0.000521	CcSEcCtD
Fingolimod—Infection—Prednisone—prostate cancer	7.21e-05	0.000518	CcSEcCtD
Fingolimod—Mediastinal disorder—Epirubicin—prostate cancer	7.21e-05	0.000517	CcSEcCtD
Fingolimod—Pruritus—Etoposide—prostate cancer	7.17e-05	0.000515	CcSEcCtD
Fingolimod—Nervous system disorder—Prednisone—prostate cancer	7.12e-05	0.000511	CcSEcCtD
Fingolimod—Alopecia—Epirubicin—prostate cancer	7.06e-05	0.000507	CcSEcCtD
Fingolimod—Skin disorder—Prednisone—prostate cancer	7.05e-05	0.000506	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Capecitabine—prostate cancer	7.04e-05	0.000505	CcSEcCtD
Fingolimod—Fatigue—Capecitabine—prostate cancer	7.03e-05	0.000505	CcSEcCtD
Fingolimod—Mental disorder—Epirubicin—prostate cancer	7e-05	0.000503	CcSEcCtD
Fingolimod—Diarrhoea—Etoposide—prostate cancer	6.93e-05	0.000498	CcSEcCtD
Fingolimod—Eye disorder—Doxorubicin—prostate cancer	6.91e-05	0.000496	CcSEcCtD
Fingolimod—Cardiac disorder—Doxorubicin—prostate cancer	6.87e-05	0.000493	CcSEcCtD
Fingolimod—Back pain—Epirubicin—prostate cancer	6.73e-05	0.000483	CcSEcCtD
Fingolimod—Angiopathy—Doxorubicin—prostate cancer	6.71e-05	0.000482	CcSEcCtD
Fingolimod—Dizziness—Etoposide—prostate cancer	6.7e-05	0.000481	CcSEcCtD
Fingolimod—Mediastinal disorder—Doxorubicin—prostate cancer	6.67e-05	0.000479	CcSEcCtD
Fingolimod—Vision blurred—Epirubicin—prostate cancer	6.56e-05	0.000471	CcSEcCtD
Fingolimod—Alopecia—Doxorubicin—prostate cancer	6.54e-05	0.000469	CcSEcCtD
Fingolimod—Paraesthesia—Prednisone—prostate cancer	6.52e-05	0.000468	CcSEcCtD
Fingolimod—Mental disorder—Doxorubicin—prostate cancer	6.48e-05	0.000465	CcSEcCtD
Fingolimod—Headache—Etoposide—prostate cancer	6.35e-05	0.000456	CcSEcCtD
Fingolimod—Fatigue—Prednisone—prostate cancer	6.26e-05	0.000449	CcSEcCtD
Fingolimod—Leukopenia—Epirubicin—prostate cancer	6.23e-05	0.000447	CcSEcCtD
Fingolimod—Back pain—Doxorubicin—prostate cancer	6.23e-05	0.000447	CcSEcCtD
Fingolimod—Palpitations—Epirubicin—prostate cancer	6.15e-05	0.000441	CcSEcCtD
Fingolimod—Cough—Epirubicin—prostate cancer	6.07e-05	0.000436	CcSEcCtD
Fingolimod—Vision blurred—Doxorubicin—prostate cancer	6.07e-05	0.000436	CcSEcCtD
Fingolimod—Asthenia—Docetaxel—prostate cancer	6.04e-05	0.000434	CcSEcCtD
Fingolimod—Hypertension—Epirubicin—prostate cancer	6.01e-05	0.000431	CcSEcCtD
Fingolimod—Pruritus—Docetaxel—prostate cancer	5.96e-05	0.000428	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	5.88e-05	0.000422	CcSEcCtD
Fingolimod—Asthenia—Capecitabine—prostate cancer	5.85e-05	0.00042	CcSEcCtD
Fingolimod—Pruritus—Capecitabine—prostate cancer	5.77e-05	0.000414	CcSEcCtD
Fingolimod—Leukopenia—Doxorubicin—prostate cancer	5.76e-05	0.000414	CcSEcCtD
Fingolimod—Diarrhoea—Docetaxel—prostate cancer	5.76e-05	0.000414	CcSEcCtD
Fingolimod—Palpitations—Doxorubicin—prostate cancer	5.69e-05	0.000408	CcSEcCtD
Fingolimod—Infection—Epirubicin—prostate cancer	5.64e-05	0.000405	CcSEcCtD
Fingolimod—Cough—Doxorubicin—prostate cancer	5.62e-05	0.000403	CcSEcCtD
Fingolimod—Diarrhoea—Capecitabine—prostate cancer	5.58e-05	0.0004	CcSEcCtD
Fingolimod—Nervous system disorder—Epirubicin—prostate cancer	5.57e-05	0.0004	CcSEcCtD
Fingolimod—Dizziness—Docetaxel—prostate cancer	5.57e-05	0.0004	CcSEcCtD
Fingolimod—Hypertension—Doxorubicin—prostate cancer	5.56e-05	0.000399	CcSEcCtD
Fingolimod—Skin disorder—Epirubicin—prostate cancer	5.52e-05	0.000396	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	5.44e-05	0.000391	CcSEcCtD
Fingolimod—Dizziness—Capecitabine—prostate cancer	5.39e-05	0.000387	CcSEcCtD
Fingolimod—Hypotension—Epirubicin—prostate cancer	5.31e-05	0.000381	CcSEcCtD
Fingolimod—Headache—Docetaxel—prostate cancer	5.28e-05	0.000379	CcSEcCtD
Fingolimod—Infection—Doxorubicin—prostate cancer	5.22e-05	0.000375	CcSEcCtD
Fingolimod—Asthenia—Prednisone—prostate cancer	5.21e-05	0.000374	CcSEcCtD
Fingolimod—Nervous system disorder—Doxorubicin—prostate cancer	5.15e-05	0.00037	CcSEcCtD
Fingolimod—Pruritus—Prednisone—prostate cancer	5.14e-05	0.000369	CcSEcCtD
Fingolimod—Headache—Capecitabine—prostate cancer	5.11e-05	0.000367	CcSEcCtD
Fingolimod—Skin disorder—Doxorubicin—prostate cancer	5.1e-05	0.000366	CcSEcCtD
Fingolimod—Paraesthesia—Epirubicin—prostate cancer	5.1e-05	0.000366	CcSEcCtD
Fingolimod—Dyspnoea—Epirubicin—prostate cancer	5.06e-05	0.000363	CcSEcCtD
Fingolimod—Diarrhoea—Prednisone—prostate cancer	4.97e-05	0.000357	CcSEcCtD
Fingolimod—Hypotension—Doxorubicin—prostate cancer	4.91e-05	0.000353	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Epirubicin—prostate cancer	4.9e-05	0.000352	CcSEcCtD
Fingolimod—Fatigue—Epirubicin—prostate cancer	4.9e-05	0.000352	CcSEcCtD
Fingolimod—Dizziness—Prednisone—prostate cancer	4.8e-05	0.000345	CcSEcCtD
Fingolimod—Paraesthesia—Doxorubicin—prostate cancer	4.72e-05	0.000339	CcSEcCtD
Fingolimod—Dyspnoea—Doxorubicin—prostate cancer	4.69e-05	0.000336	CcSEcCtD
Fingolimod—Headache—Prednisone—prostate cancer	4.55e-05	0.000327	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Doxorubicin—prostate cancer	4.54e-05	0.000326	CcSEcCtD
Fingolimod—Fatigue—Doxorubicin—prostate cancer	4.53e-05	0.000325	CcSEcCtD
Fingolimod—Asthenia—Epirubicin—prostate cancer	4.08e-05	0.000293	CcSEcCtD
Fingolimod—Pruritus—Epirubicin—prostate cancer	4.02e-05	0.000288	CcSEcCtD
Fingolimod—Diarrhoea—Epirubicin—prostate cancer	3.89e-05	0.000279	CcSEcCtD
Fingolimod—Asthenia—Doxorubicin—prostate cancer	3.77e-05	0.000271	CcSEcCtD
Fingolimod—Dizziness—Epirubicin—prostate cancer	3.76e-05	0.00027	CcSEcCtD
Fingolimod—Pruritus—Doxorubicin—prostate cancer	3.72e-05	0.000267	CcSEcCtD
Fingolimod—Diarrhoea—Doxorubicin—prostate cancer	3.6e-05	0.000258	CcSEcCtD
Fingolimod—Headache—Epirubicin—prostate cancer	3.56e-05	0.000255	CcSEcCtD
Fingolimod—Dizziness—Doxorubicin—prostate cancer	3.48e-05	0.000249	CcSEcCtD
Fingolimod—Headache—Doxorubicin—prostate cancer	3.29e-05	0.000236	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—MYC—prostate cancer	4.38e-06	2.35e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TGFB1—prostate cancer	4.37e-06	2.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CBR1—prostate cancer	4.35e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TST—prostate cancer	4.35e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ADI1—prostate cancer	4.35e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CSAD—prostate cancer	4.35e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PSAT1—prostate cancer	4.35e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GRHL1—prostate cancer	4.35e-06	2.33e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTA1—prostate cancer	4.31e-06	2.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP7B1—prostate cancer	4.29e-06	2.3e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTAP—prostate cancer	4.29e-06	2.3e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—EGFR—prostate cancer	4.28e-06	2.3e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HSD3B2—prostate cancer	4.26e-06	2.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NAT2—prostate cancer	4.26e-06	2.28e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTO1—prostate cancer	4.26e-06	2.28e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—prostate cancer	4.26e-06	2.28e-05	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—AKT1—prostate cancer	4.23e-06	2.27e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—PIK3CA—prostate cancer	4.2e-06	2.25e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SULT1E1—prostate cancer	4.18e-06	2.24e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SRD5A1—prostate cancer	4.18e-06	2.24e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—prostate cancer	4.1e-06	2.2e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—prostate cancer	4.1e-06	2.2e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PLCB2—prostate cancer	4.08e-06	2.19e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LRP2—prostate cancer	4.08e-06	2.19e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2C18—prostate cancer	4.08e-06	2.19e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—TP53—prostate cancer	4.06e-06	2.18e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UGT2B15—prostate cancer	4.05e-06	2.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UGT2B17—prostate cancer	4.05e-06	2.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CKMT2—prostate cancer	4.05e-06	2.17e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GRHPR—prostate cancer	4.05e-06	2.17e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—KRAS—prostate cancer	4.05e-06	2.17e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—P4HB—prostate cancer	4.01e-06	2.15e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACSL4—prostate cancer	3.99e-06	2.14e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD17B3—prostate cancer	3.99e-06	2.14e-05	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—AKT1—prostate cancer	3.93e-06	2.1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC22A1—prostate cancer	3.9e-06	2.09e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ARG2—prostate cancer	3.82e-06	2.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PHGDH—prostate cancer	3.82e-06	2.05e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UMPS—prostate cancer	3.82e-06	2.05e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SULT2B1—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PGAM2—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAGLU—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RFK—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MBTPS1—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AOX1—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM3—prostate cancer	3.81e-06	2.04e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SULT2A1—prostate cancer	3.8e-06	2.04e-05	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—AKT1—prostate cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—AKT1—prostate cancer	3.78e-06	2.03e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LDHB—prostate cancer	3.75e-06	2.01e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MED12—prostate cancer	3.74e-06	2e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—prostate cancer	3.72e-06	1.99e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—PIK3CA—prostate cancer	3.72e-06	1.99e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GNG5—prostate cancer	3.71e-06	1.99e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP3A5—prostate cancer	3.68e-06	1.97e-05	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—AKT1—prostate cancer	3.63e-06	1.95e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AMACR—prostate cancer	3.61e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP3A43—prostate cancer	3.61e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAT1—prostate cancer	3.61e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SRD5A2—prostate cancer	3.61e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—DEGS1—prostate cancer	3.61e-06	1.93e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—TP53—prostate cancer	3.6e-06	1.93e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA3—prostate cancer	3.57e-06	1.91e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PDHA1—prostate cancer	3.56e-06	1.91e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—UCP3—prostate cancer	3.56e-06	1.91e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TCN2—prostate cancer	3.56e-06	1.91e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA3—prostate cancer	3.56e-06	1.91e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD17B1—prostate cancer	3.44e-06	1.84e-05	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—AKT1—prostate cancer	3.43e-06	1.84e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—HPGDS—prostate cancer	3.41e-06	1.83e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC22A3—prostate cancer	3.39e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD3B1—prostate cancer	3.39e-06	1.82e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2C19—prostate cancer	3.38e-06	1.81e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ACHE—prostate cancer	3.3e-06	1.77e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTT1—prostate cancer	3.3e-06	1.77e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—prostate cancer	3.29e-06	1.76e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP2A6—prostate cancer	3.27e-06	1.75e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA4—prostate cancer	3.25e-06	1.74e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TBXAS1—prostate cancer	3.25e-06	1.74e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKR1C3—prostate cancer	3.18e-06	1.7e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA2—prostate cancer	3.17e-06	1.7e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PRKACB—prostate cancer	3.16e-06	1.69e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SULT1A1—prostate cancer	3.13e-06	1.68e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ABCG5—prostate cancer	3.13e-06	1.68e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP17A1—prostate cancer	3.13e-06	1.68e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—B4GALT4—prostate cancer	3.07e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGD—prostate cancer	3.07e-06	1.64e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTA1—prostate cancer	3.06e-06	1.64e-05	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—AKT1—prostate cancer	3.04e-06	1.63e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTO1—prostate cancer	3.02e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HSD3B2—prostate cancer	3.02e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NAT2—prostate cancer	3.02e-06	1.62e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA2—prostate cancer	2.98e-06	1.6e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PLCB2—prostate cancer	2.9e-06	1.55e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LRP2—prostate cancer	2.9e-06	1.55e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2C18—prostate cancer	2.9e-06	1.55e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TNFRSF21—prostate cancer	2.88e-06	1.55e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—SLC5A5—prostate cancer	2.84e-06	1.52e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—P4HB—prostate cancer	2.84e-06	1.52e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP7B1—prostate cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTAP—prostate cancer	2.81e-06	1.5e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC22A1—prostate cancer	2.77e-06	1.48e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NQO1—prostate cancer	2.75e-06	1.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SULT1E1—prostate cancer	2.73e-06	1.47e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SRD5A1—prostate cancer	2.73e-06	1.47e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TH—prostate cancer	2.71e-06	1.45e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SULT2A1—prostate cancer	2.69e-06	1.44e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP3A4—prostate cancer	2.68e-06	1.43e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MED12—prostate cancer	2.65e-06	1.42e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1B1—prostate cancer	2.63e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GNG5—prostate cancer	2.63e-06	1.41e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACSL4—prostate cancer	2.61e-06	1.4e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD17B3—prostate cancer	2.61e-06	1.4e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GGT1—prostate cancer	2.55e-06	1.37e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA3—prostate cancer	2.53e-06	1.36e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NCOA1—prostate cancer	2.51e-06	1.35e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UMPS—prostate cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PHGDH—prostate cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ARG2—prostate cancer	2.5e-06	1.34e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP19A1—prostate cancer	2.47e-06	1.33e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LDHB—prostate cancer	2.45e-06	1.31e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—HPGDS—prostate cancer	2.42e-06	1.3e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP3A5—prostate cancer	2.41e-06	1.29e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2C19—prostate cancer	2.4e-06	1.29e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—RXRA—prostate cancer	2.39e-06	1.28e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ACHE—prostate cancer	2.34e-06	1.26e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTT1—prostate cancer	2.34e-06	1.26e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—UCP3—prostate cancer	2.32e-06	1.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PDHA1—prostate cancer	2.32e-06	1.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA3—prostate cancer	2.32e-06	1.25e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TCN2—prostate cancer	2.32e-06	1.25e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2A6—prostate cancer	2.32e-06	1.24e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—COMT—prostate cancer	2.3e-06	1.23e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTP1—prostate cancer	2.29e-06	1.23e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKR1C3—prostate cancer	2.25e-06	1.21e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ITPR1—prostate cancer	2.25e-06	1.21e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PRKACB—prostate cancer	2.24e-06	1.2e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP17A1—prostate cancer	2.22e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC22A3—prostate cancer	2.22e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD3B1—prostate cancer	2.22e-06	1.19e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TYMS—prostate cancer	2.13e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA4—prostate cancer	2.13e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TBXAS1—prostate cancer	2.13e-06	1.14e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA2—prostate cancer	2.11e-06	1.13e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—GSTM1—prostate cancer	2.1e-06	1.13e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA2—prostate cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—LPL—prostate cancer	2.07e-06	1.11e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ABCG5—prostate cancer	2.05e-06	1.1e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SULT1A1—prostate cancer	2.05e-06	1.1e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—SLC5A5—prostate cancer	2.02e-06	1.08e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTA1—prostate cancer	2e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CYP1A1—prostate cancer	1.99e-06	1.07e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ERCC2—prostate cancer	1.98e-06	1.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HSD3B2—prostate cancer	1.98e-06	1.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTO1—prostate cancer	1.98e-06	1.06e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NAT2—prostate cancer	1.98e-06	1.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP2E1—prostate cancer	1.97e-06	1.06e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NQO1—prostate cancer	1.95e-06	1.04e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TH—prostate cancer	1.92e-06	1.03e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP3A4—prostate cancer	1.9e-06	1.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PLCB2—prostate cancer	1.9e-06	1.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LRP2—prostate cancer	1.9e-06	1.02e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2C18—prostate cancer	1.9e-06	1.02e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1B1—prostate cancer	1.87e-06	1e-05	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—MTHFR—prostate cancer	1.86e-06	9.97e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—P4HB—prostate cancer	1.86e-06	9.96e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PPARA—prostate cancer	1.82e-06	9.78e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GGT1—prostate cancer	1.81e-06	9.69e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC22A1—prostate cancer	1.81e-06	9.69e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NCOA1—prostate cancer	1.78e-06	9.55e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SULT2A1—prostate cancer	1.76e-06	9.44e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP19A1—prostate cancer	1.76e-06	9.41e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MED12—prostate cancer	1.73e-06	9.29e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GNG5—prostate cancer	1.72e-06	9.22e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CAV1—prostate cancer	1.72e-06	9.19e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—RXRA—prostate cancer	1.69e-06	9.08e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA3—prostate cancer	1.66e-06	8.88e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—COMT—prostate cancer	1.63e-06	8.75e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTP1—prostate cancer	1.62e-06	8.71e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ITPR1—prostate cancer	1.6e-06	8.57e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—HPGDS—prostate cancer	1.58e-06	8.47e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2C19—prostate cancer	1.57e-06	8.42e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CG—prostate cancer	1.56e-06	8.37e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTT1—prostate cancer	1.53e-06	8.21e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ACHE—prostate cancer	1.53e-06	8.21e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.51e-06	8.12e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TYMS—prostate cancer	1.51e-06	8.1e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—GSTM1—prostate cancer	1.49e-06	8e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—INS—prostate cancer	1.48e-06	7.93e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.47e-06	7.9e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PRKACB—prostate cancer	1.47e-06	7.86e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—LPL—prostate cancer	1.47e-06	7.85e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.45e-06	7.78e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—CREBBP—prostate cancer	1.45e-06	7.76e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.42e-06	7.59e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ERCC2—prostate cancer	1.4e-06	7.52e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA2—prostate cancer	1.38e-06	7.41e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CD—prostate cancer	1.37e-06	7.36e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—MTHFR—prostate cancer	1.32e-06	7.07e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.32e-06	7.07e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—NOS3—prostate cancer	1.3e-06	6.95e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PPARA—prostate cancer	1.29e-06	6.94e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.29e-06	6.9e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NQO1—prostate cancer	1.27e-06	6.83e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TH—prostate cancer	1.26e-06	6.73e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.22e-06	6.54e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CAV1—prostate cancer	1.22e-06	6.52e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CB—prostate cancer	1.2e-06	6.42e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTGS2—prostate cancer	1.19e-06	6.36e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GGT1—prostate cancer	1.18e-06	6.34e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NCOA1—prostate cancer	1.16e-06	6.24e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.15e-06	6.15e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.11e-06	5.94e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—RXRA—prostate cancer	1.11e-06	5.94e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—COMT—prostate cancer	1.07e-06	5.72e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTP1—prostate cancer	1.06e-06	5.69e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—INS—prostate cancer	1.05e-06	5.62e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ITPR1—prostate cancer	1.05e-06	5.6e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PTEN—prostate cancer	1.03e-06	5.54e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—CREBBP—prostate cancer	1.03e-06	5.51e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TYMS—prostate cancer	9.88e-07	5.29e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—EP300—prostate cancer	9.87e-07	5.29e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—GSTM1—prostate cancer	9.76e-07	5.23e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CD—prostate cancer	9.75e-07	5.22e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—LPL—prostate cancer	9.58e-07	5.14e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.25e-07	4.96e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—NOS3—prostate cancer	9.2e-07	4.93e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ERCC2—prostate cancer	9.18e-07	4.92e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—MTHFR—prostate cancer	8.63e-07	4.62e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CB—prostate cancer	8.5e-07	4.55e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PPARA—prostate cancer	8.46e-07	4.54e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTGS2—prostate cancer	8.42e-07	4.51e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CAV1—prostate cancer	7.96e-07	4.27e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PTEN—prostate cancer	7.34e-07	3.93e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—PIK3CA—prostate cancer	7.3e-07	3.91e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.25e-07	3.88e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—EP300—prostate cancer	7e-07	3.75e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—INS—prostate cancer	6.86e-07	3.68e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—CREBBP—prostate cancer	6.72e-07	3.6e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.37e-07	3.42e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—NOS3—prostate cancer	6.02e-07	3.22e-06	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AKT1—prostate cancer	5.96e-07	3.2e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.55e-07	2.98e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTGS2—prostate cancer	5.5e-07	2.95e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.18e-07	2.78e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PTEN—prostate cancer	4.8e-07	2.57e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—EP300—prostate cancer	4.58e-07	2.45e-06	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AKT1—prostate cancer	4.23e-07	2.27e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.39e-07	1.81e-06	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AKT1—prostate cancer	2.77e-07	1.48e-06	CbGpPWpGaD
